Results 91 to 100 of about 114,029 (285)
Clinical Safety of Extended Interval Dosing of Nivolumab in Patients with Melanoma
Extended interval dosing regimens of immune checkpoint inhibitors have been implemented widely. However, their approval was mainly based on pharmacokinetic modeling and simulations. Consequently, comparative safety data of extended interval dosing regimens in a real‐world setting are limited.
Ruben Malmberg +10 more
wiley +1 more source
Traditionally, clinical outcomes measuring how a patient feels, functions, or survives are preferred endpoints in clinical trials; however, some may take a long time to manifest in slowly developing diseases. Biomarkers, if properly validated, can serve as surrogate endpoints, acting as substitutes for clinical outcomes.
Renske Johanna Grupstra +4 more
wiley +1 more source
Adrenal tumors. Literature review
Tumors of adrenal origin may be derived from the cortex or the medulla, which depends on the type of functionality that can be developed. Adrenal masses have varying styles.
Vivian de la Caridad Betancourt Rodríguez +1 more
doaj
Case report: Imaging of adrenal adenomatoid tumors: reports of two cases and review of literature
Adenomatoid tumors (ATs) are uncommon, benign tumors of mesothelial origin, most frequently found in the genital tracts of both sexes. Extragenital localization sites, such as adrenal glands, are extremely rare.
Yuanyuan Wu +7 more
doaj +1 more source
Expressions of LncRNA HOTAIR and VEGF in adrenal malignant tumors and their prognostic significance
Objective To explore the expression levels of long non-coding RNAHOX transcript antisense intergenic RNA(LncRNAHOTAIR)and vascular endothelial growth factor(VEGF)in patients with adrenal malignant tumor,and analyze their prognostic relationship.Methods ...
Du Xue-qian +2 more
doaj
ABSTRACT Background Accessory spleens result from failure of splenic fusion during development and are occasionally located in the pancreatic tail, radiographically appearing as solid or solid/cystic lesions. Fine needle aspiration (FNA) easily identifies accessory spleens in most samples based on architecture and using CD8 to highlight splenic ...
Adeyinka Akinsanya +5 more
wiley +1 more source
Case Report: Adrenal schwannoma associated with ganglioneuroma
BackgroundAn adrenal collision tumor (ACT) denotes the presence of distinct tumors with diverse behavioral, genetic, and histological features independently co-existing within the adrenal tissue without intermingling, and occurrences of such cases are ...
Dong-Lin He +4 more
doaj +1 more source
Integrative multi-omics analysis identifies a prognostic miRNA signature and a targetable miR-21-3p/TSC2/ mTOR axis in metastatic pheochromocytoma/ paraganglioma [PDF]
Artículo escrito por un elevado número de autores, solo se referencian el que aparece en primer lugar y los autores pertenecientes a la UAMPheochromocytomas and paragangliomas (PPGLs) are rare neuroendocrine tumors that present variable outcomes.
Alvarez - Escola, Cristina +1 more
core +2 more sources
Abstract Background CD163 is a scavenger receptor predominantly expressed on the surfaces of macrophages in various mammalian species and is a marker of anti‐inflammatory (M2‐like) macrophages. High density of CD163‐positive tumor‐associated macrophages (TAMs) is associated with worse prognosis in various patient tumors.
Yoichi Saito +9 more
wiley +1 more source
An incidental large adrenal schwannoma: A case report
Adrenal schwannoma is a rare tumor of Schwann cell origin that represents less than 0.2% of all adrenal tumors. These typically benign tumors are most often found in the head, neck, and limbs.
Ryan C. Rizk, MS +4 more
doaj +1 more source

